6ER-21071-63101
2 vaccinations
3 coded responses
25 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 983 / WA
- Registered
- 2021-06-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-06-01
Registered in v-safe
-
2021-06-01
Dose 1 — Pfizer-BioNTech
- 2021-06-01
- 2021-06-02
-
2021-06-03
Survey response — days 1–6 daily, dose 1MedDRA: Hyperhidrosis — Feeling: Good · Fatigue or tirednessFree text: SweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-04
Survey response — days 1–6 daily, dose 1MedDRA: Night sweats — Feeling: Good · ChillsFree text: Night sweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-05
- 2021-06-06
- 2021-06-07
- 2021-06-08
- 2021-06-15
-
2021-06-22
Dose 2 — Pfizer-BioNTech
- 2021-06-22
- 2021-06-23
- 2021-06-24
- 2021-06-25
- 2021-06-26
- 2021-06-27
- 2021-06-28
- 2021-06-29
- 2021-07-06
- 2021-07-13
- 2021-07-20
- 2021-07-27
- 2021-08-03
- 2021-09-22
- 2021-12-21
-
2022-06-22
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-06-22
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-06-24
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-01 | Pfizer-BioNTech | |
| 2 | 2021-06-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-06-22 | Successful 2022-06-24 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Sweating
Systemic reaction (other): Night sweating
Release 12 — 12 months, dose 2
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Night sweats | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release